Author

Liu Zhonglin

Houston MethodistPrimary ORCID profile (0009-0005-5742-3973 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Liu ZhongliniD1 paper · University of Hong Kong

Biology Disciplines

Click to filter author papers

Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Andrei M. MikheeviD· 1 shared Anton V. LiopoiD· 1 shared Elias PerliiD· 1 shared Gavin Wayne BritziD· 1 shared Karthik Mouli· 1 shared Manohar M. KodavatiiD· 1 shared Muralidhar L. HegdeiD· 1 shared Paul J. DerryiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperNeuroscience

Andrei M. MikheevORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Multifunctional nanozyme therapy accelerates hematoma clearance and attenuates genome damage and senescence after intracerebral hemorrhage

Vikas H. Malojirao, Andrei M. Mikheev, Manohar M. Kodavati, Anton V. Liopo, Paul J. Derry, Elias Perli, Karthik Mouli, Shu Zhang, Liu Zhonglin, Tang Xiufeng, Gavin Wayne Britz, Philip J. Horner, Thomas A. Kent, Muralidhar L. Hegde

This study evaluates a multifunctional nanozyme therapy for intracerebral hemorrhage, showing it accelerates hematoma clearance and reduces genome damage and senescence.

bioRxiv · Mar 16, 2026 · PreprintNeuroscience